Bioprocess Containers Market is Set to Witness Exponential Growth during 2021-2026

Contact Us
Tejashri
121/7E Avenue Franklin Roosevelt 1050 Brussels
Brussels
Brussels 1050 
Belgium
Phone:+ 32 498 86 80 79
tejashri.k@meditechinsights.com

The Global Bioprocess Containers Market valued at $3 billion (2021) is set to witness a healthy growth rate of 27% in the next 5 years. Some of the important drivers propelling the global bioprocess containers market are the benefits of ready-to-use single-use bioprocess container systems, rising biologics & vaccines market, and growing biopharmaceutical R&D.

Advantages of Ready-To-Use Single-Use Bioprocess Container Systems Fuels the Bioprocess Containers Market Demand
Single-use technology (SUT) products are widely accepted for the manufacturing of vaccines and biologics.

Some of the main advantages boosting its demand are:

Operational Benefits & Reduced Risk of Cross-Contamination: Bioprocess container systems reduce the risk of cross-contamination. Moreover, the elimination of cleaning-in-place and sterilization-in-place (CIP/SIP) systems reduce setup, maintenance, and validation times, thereby enabling increased output

Ready Integration: Bioprocess container components work well in all stages in the production of therapeutic biologics and vaccines

Reduction in Cost of Goods Sold (COGS): Bioprocess container systems reduce capital investment and labor costs, which in turn leads to a reduction in COGS

Scalability: Bioprocess container systems are well suited for use from benchtop to production scale processes

Explore Premium Report on Bioprocess Containers Market @ https://meditechinsights.com/bioprocess-containers-market/

High Development & Manufacturing Costs of Biologics Coupled with Its Patent Expiry Likely to Drive the Demand of Single-Use Bioprocessing Technologies
Currently, Biologics hold nearly half of the pharmacological market for oncology. Nearly 20 oncology biologics patents are anticipated to expire by 2023. Patent expiry of biologics is projected to result in a rise in the R&D of biologics, and a turn shift of biologics from the pipeline stage to commercial production.

The expansion of biologics including cell & gene therapies and therapeutic vaccines demand high sterility and hence biologics are progressively being manufactured using single-use equipment and consumables.

As the development and manufacturing costs of biologics are very high, numerous biopharmaceutical manufacturers are uniting single-use bioprocessing technologies into their development processes.

“Biopharmaceutical manufacturers use a range of bioprocess containers (BPCs) during the production and storage of biopharmaceuticals. The trend of “single-use” or “disposable” BPC technologies in the biopharmaceutical industry enables greater flexibility and better use of production facilities that are increasingly designed for multiple products.” – Senior Director, Leading Bioprocess Container (BPC) Manufacturer, United States

Competitive Landscape Analysis of Bioprocess Containers Market
The global bioprocess containers market is marked by the presence of key players such as Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck Millipore (Germany), and others.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com